{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:48:48Z","timestamp":1791593328461,"version":"4.3.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>US Centers for Disease Control and Prevention guidelines currently recommend triple-therapy antimicrobial treatment for anthrax meningitis. In the Kyrgyz Republic, a country with endemic anthrax, cutaneous anthrax patients are routinely hospitalized and treated successfully with only monotherapy or dual therapy. Clinical algorithms have been developed to identify patients with likely anthrax meningitis based on signs and symptoms alone. We sought to retrospectively identify likely meningitis patients in the Kyrgyz Republic using a clinical algorithm and evaluate risk factors and their outcomes by type of treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective chart review of cutaneous anthrax patients in the Kyrgyz Republic from 2005 through 2012. Using previous methods, we developed a highly specific algorithm to categorize patients by meningitis status. We then evaluated patient risk factors, treatments, and outcomes by disease severity and meningitis status.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We categorized 37 of 230 cutaneous anthrax patients as likely having meningitis. All 37 likely meningitis patients survived, receiving only mono- or dual-therapy antimicrobials. We identified underlying medical conditions, such as obesity, hypertension, and chronic obstructive pulmonary disease, and tobacco and alcohol use, as potential risk factors for severe anthrax and anthrax meningitis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Based on our analyses, treatment of anthrax meningitis may not require 3 antimicrobials, which could impact future anthrax treatment recommendations. In addition, chronic comorbidities may increase risk for severe anthrax and anthrax meningitis. Future research should further investigate potential risk factors for severe anthrax and their impact on laboratory-confirmed meningitis and evaluate mono- and dual-therapy antimicrobial regimens for anthrax meningitis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciac537","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T18:50:09Z","timestamp":1666032609000},"page":"S478-S486","source":"Crossref","is-referenced-by-count":10,"title":["Risk Factors for Severe Cutaneous Anthrax in a Retrospective Case Series and Use of a Clinical Algorithm to Identify Likely Meningitis and Evaluate Treatment Outcomes, Kyrgyz Republic, 2005\u20132012"],"prefix":"10.1093","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2611-6426","authenticated-orcid":false,"given":"Ainura","family":"Kutmanova","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, International Higher School of Medicine , Bishkek , Kyrgyz Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saparbai","family":"Zholdoshev","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Microbiology with a course of Infectious Diseases, Osh State University , Osh , Kyrgyz Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M","family":"Roguski","sequence":"additional","affiliation":[{"name":"Division of High-Consequence Pathogens and Pathology, US Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melis","family":"Sholpanbay uulu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Kyrgyz State Medical Academy , Bishkek , Kyrgyz Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa K","family":"Person","sequence":"additional","affiliation":[{"name":"Division of High-Consequence Pathogens and Pathology, US Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Cook","sequence":"additional","affiliation":[{"name":"Division of High-Consequence Pathogens and Pathology, US Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bugrysheva","sequence":"additional","affiliation":[{"name":"Division of Preparedness and Emerging Infections, US Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Nadol","sequence":"additional","affiliation":[{"name":"CDC Kyrgyzstan, US Centers for Disease Control and Prevention , Bishkek , Kyrgyz Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisuluu","family":"Buranchieva","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, International Higher School of Medicine , Bishkek , Kyrgyz Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lira","family":"Imanbaeva","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, International Higher School of Medicine , Bishkek , Kyrgyz Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainura","family":"Dzhangazieva","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, International Higher School of Medicine , Bishkek , Kyrgyz Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6538-8665","authenticated-orcid":false,"given":"William A","family":"Bower","sequence":"additional","affiliation":[{"name":"Division of High-Consequence Pathogens and Pathology, US Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Hendricks","sequence":"additional","affiliation":[{"name":"Division of High-Consequence Pathogens and Pathology, US Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"2022113008295430100_ciac537-B1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1212\/WNL.59.3.327","article-title":"Anthrax meningoencephalitis","volume":"59","author":"Lanska","year":"2002","journal-title":"Neurology"},{"key":"2022113008295430100_ciac537-B2","doi-asserted-by":"crossref","first-page":"e130687","DOI":"10.3201\/eid2002.130687","article-title":"Centers for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults","volume":"20","author":"Hendricks","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2022113008295430100_ciac537-B3","doi-asserted-by":"crossref","first-page":"e1411-36","DOI":"10.1542\/peds.2014-0564","article-title":"Pediatric anthrax clinical management","volume":"133","author":"Bradley","year":"2014","journal-title":"Pediatrics"},{"key":"2022113008295430100_ciac537-B4","doi-asserted-by":"crossref","first-page":"e130611","DOI":"10.3201\/eid2002.130611","article-title":"Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women","volume":"20","author":"Meaney-Delman","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2022113008295430100_ciac537-B5","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/cid\/ciw184","article-title":"Identifying meningitis during an anthrax mass casualty incident: systematic review of systemic anthrax since 1880","volume":"62","author":"Katharios-Lanwermeyer","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2022113008295430100_ciac537-B6","doi-asserted-by":"crossref","first-page":"S459","DOI":"10.1093\/cid\/ciac533","article-title":"Risk factors for death or meningitis in adults hospitalized for cutaneous anthrax, 1950\u20132018: a systematic review","volume":"75","author":"Thompson","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2022113008295430100_ciac537-B7","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jiph.2020.02.043","article-title":"Human anthrax in Kyrgyz Republic: epidemiology and clinical features","volume":"13","author":"Kutmanova","year":"2020","journal-title":"J Infect Public Health"},{"key":"2022113008295430100_ciac537-B8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/BF01591362","article-title":"Evaluation of the anthraxin skin test for diagnosis of acute and past human anthrax","volume":"15","author":"Shlyakhov","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2022113008295430100_ciac537-B9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International Pediatric Sepsis Consensus Conference: definitions for sepsis and organ dysfunction in pediatrics","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"2022113008295430100_ciac537-B10","doi-asserted-by":"crossref","first-page":"S468","DOI":"10.1093\/cid\/ciac546","article-title":"Algorithms for the identification of anthrax meningitis during a mass casualty event based on a systematic review of systemic anthrax from 1880 through 2018","volume":"75","author":"Binney","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2022113008295430100_ciac537-B11","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1093\/cid\/ciac534","article-title":"Clinical features of patients hospitalized for all routes of anthrax, 1880\u20132018: a systematic review","volume":"75","author":"Hendricks","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2022113008295430100_ciac537-B12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/CMR.00070-09","article-title":"Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis","volume":"23","author":"Brouwer","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"2022113008295430100_ciac537-B13","author":"World Health Organization"},{"key":"2022113008295430100_ciac537-B14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/23744235.2017.1285046","article-title":"Risk factors for community-acquired bacterial meningitis","volume":"49","author":"Lundbo","year":"2017","journal-title":"Infect Dis (Lond)"},{"key":"2022113008295430100_ciac537-B15","first-page":"16074","article-title":"Community-acquired bacterial meningitis","volume-title":"Nat Rev Dis Primers","author":"van de Beek","year":"2016"},{"key":"2022113008295430100_ciac537-B16","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3389\/fnins.2018.00930","article-title":"Impact of metabolic syndrome on neuroinflammation and the blood-brain barrier","volume":"12","author":"Van Dyken","year":"2018","journal-title":"Front Neurosci"},{"key":"2022113008295430100_ciac537-B17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/ajcp\/17.9.719","article-title":"Anthrax meningitis; report of a case of internal anthrax with recovery","volume":"17","author":"Shanahan","year":"1947","journal-title":"Am J Clin Pathol"},{"key":"2022113008295430100_ciac537-B18","first-page":"533","article-title":"The treatment of human anthrax with penicillin","volume":"2","author":"Weinstein","year":"1948","journal-title":"Am Pract Dig Treat"},{"key":"2022113008295430100_ciac537-B19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1542\/peds.50.2.329","article-title":"Survival in anthrax meningitis","volume":"50","author":"Tahernia","year":"1972","journal-title":"Pediatrics"},{"key":"2022113008295430100_ciac537-B20","first-page":"337","article-title":"Anthrax meningitis. Report of two cases","volume":"50","author":"Tengio","year":"1973","journal-title":"East Afr Med J"},{"key":"2022113008295430100_ciac537-B21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0002-9343(77)90358-8","article-title":"Survival of a patient with intestinal anthrax","volume":"62","author":"Nalin","year":"1977","journal-title":"Am J Med"},{"key":"2022113008295430100_ciac537-B22","first-page":"315","article-title":"Successfully treated primary anthrax meningitis","volume":"32","author":"Khanna","year":"1989","journal-title":"Indian J Pathol Microbiol"},{"key":"2022113008295430100_ciac537-B23","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/00006454-199312000-00020","article-title":"Bacillus anthracis as a cause of bacterial meningitis","volume":"12","author":"Tabatabaie","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"2022113008295430100_ciac537-B24","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"2022113008295430100_ciac537-B25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/09546630305547","article-title":"Cutaneous anthrax associated with facial palsy: case report and literature review","volume":"14","author":"Faghihi","year":"2003","journal-title":"J Dermatolog Treat"},{"key":"2022113008295430100_ciac537-B26","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/j.1468-1331.2007.01868.x","article-title":"Anthrax meningoencephalitis successfully treated","volume":"14","author":"Bindu","year":"2007","journal-title":"Eur J Neurol"},{"key":"2022113008295430100_ciac537-B27","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3201\/eid2009.131481","article-title":"Confirmed Bacillus anthracis infection among persons who inject drugs, Scotland, 2009\u20132010","volume":"20","author":"Booth","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2022113008295430100_ciac537-B28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cimid.2012.02.005","article-title":"Antimicrobial susceptibility and molecular subtyping of 55 Turkish Bacillus anthracis strains using 25-loci multiple-locus VNTR analysis","volume":"35","author":"Ortatatli","year":"2012","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"2022113008295430100_ciac537-B29","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1128\/AAC.46.7.2307-2309.2002","article-title":"Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000","volume":"46","author":"Cavallo","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2022113008295430100_ciac537-B30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.publhealth.29.020907.090904","article-title":"Industrial food animal production, antimicrobial resistance, and human health","volume":"29","author":"Silbergeld","year":"2008","journal-title":"Annu Rev Public Health"},{"key":"2022113008295430100_ciac537-B31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1473-3099(14)70071-4","article-title":"Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe","volume":"14","author":"Versporten","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"2022113008295430100_ciac537-B32","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.ARBA-0009-2017","article-title":"Antimicrobial resistance: a one health perspective","volume":"6","author":"McEwen","year":"2018","journal-title":"Microbiol Spectr"},{"key":"2022113008295430100_ciac537-B33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.20506\/rst.31.1.2108","article-title":"Human use of antimicrobial agents","volume":"31","author":"Zarb","year":"2012","journal-title":"Rev Sci Tech"},{"key":"2022113008295430100_ciac537-B34","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically","author":"Clinical and Laboratory Standards Institute","year":"2018","edition":"11th Ed"},{"key":"2022113008295430100_ciac537-B35","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1128\/JCM.40.6.1902-1907.2002","article-title":"Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods","volume":"40","author":"Mohammed","year":"2002","journal-title":"J Clin Microbiol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/Supplement_3\/S478\/47441980\/ciac537.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/Supplement_3\/S478\/47441980\/ciac537.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T14:51:01Z","timestamp":1669819861000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/Supplement_3\/S478\/6762177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":35,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2022,10,17]]},"published-print":{"date-parts":[[2022,10,17]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac537","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,15]]},"published":{"date-parts":[[2022,10,15]]}}}